Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma

作者: Joeri Both , Oscar Krijgsman , Johannes Bras , Gerard R. Schaap , Frank Baas

DOI: 10.1371/JOURNAL.PONE.0115835

关键词:

摘要: Osteosarcoma is an aggressive bone tumor that preferentially develops in adolescents. The characterized by abundance of genomic aberrations, which hampers the identification driver genes involved osteosarcoma tumorigenesis. Our study aims to identify these investigation focal copy number aberrations (CNAs, <3 Mb). For this purpose, we subjected 26 primary tumors patients high-resolution single nucleotide polymorphism array analyses and identified 139 somatic CNAs. Of these, 72 had at least one gene located within or overlapping CNA, with a total 94 genes. 84 genes, expression status 31 samples was determined microarray analysis. This enabled us over- underexpression more than 35% cases accordance their (gain loss). These candidate were subsequently validated independent set furthermore corroborated as verifying role other types. We CMTM8 new suppressor GPR177 oncogene osteosarcoma. In osteosarcoma, has been shown suppress EGFR signaling. types, known activity oncogenic protein c-Met overexpressed upstream regulator Wnt-pathway. Further studies are needed determine whether proteins also exert latter functions

参考文章(58)
G Bacci, A Briccoli, S Ferrari, A Longhi, M Mercuri, R Capanna, D Donati, S Lari, C Forni, M DePaolis, Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol European Journal of Cancer. ,vol. 37, pp. 2030- 2039 ,(2001) , 10.1016/S0959-8049(01)00229-5
Giulia Ottaviani, Norman Jaffe, The etiology of osteosarcoma. Cancer treatment and research. ,vol. 152, pp. 15- 32 ,(2009) , 10.1007/978-1-4419-0284-9_2
Marieke L. Kuijjer, Pancras C.W. Hogendoorn, Anne-Marie Cleton-Jansen, Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor International Journal of Cancer. ,vol. 133, pp. 2512- 2521 ,(2013) , 10.1002/IJC.28124
Keiichi Iwaya, Hitoshi Ogawa, Masahiko Kuroda, Miki Izumi, Tsuyoshi Ishida, Kiyoshi Mukai, Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis Clinical & Experimental Metastasis. ,vol. 20, pp. 525- 529 ,(2003) , 10.1023/A:1025821229013
Federica Di Sano, Barbara Fazi, Roberta Tufi, Roberta Nardacci, Mauro Piacentini, Reticulon‐1C acts as a molecular switch between endoplasmic reticulum stress and genotoxic cell death pathway in human neuroblastoma cells Journal of Neurochemistry. ,vol. 102, pp. 345- 353 ,(2007) , 10.1111/J.1471-4159.2007.04479.X
Wenjuan Zhang, Michelle C. Mendoza, Xiaolei Pei, Didem Ilter, Sarah J. Mahoney, Yingmei Zhang, Dalong Ma, John Blenis, Ying Wang, Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes via c-MET/Extracellular Signal-regulated Kinase (ERK) Signaling Journal of Biological Chemistry. ,vol. 287, pp. 11850- 11858 ,(2012) , 10.1074/JBC.M111.258236
Angélica Regina Cappellari, Gabriela Jouglard Vasques, Luci Bavaresco, Elizandra Braganhol, Ana Maria Oliveira Battastini, Involvement of ecto-5′-nucleotidase/CD73 in U138MG glioma cell adhesion Molecular and Cellular Biochemistry. ,vol. 359, pp. 315- 322 ,(2012) , 10.1007/S11010-011-1025-9
Jun Ah Lee, Yunmi Ko, Dong Ho Kim, Jung Sub Lim, Chang-Bae Kong, Wan Hyeong Cho, Dae-Geun Jeon, Soo-Yong Lee, Jae-Soo Koh, Epidermal Growth Factor Receptor: Is It a Feasible Target for the Treatment of Osteosarcoma? Cancer Research and Treatment. ,vol. 44, pp. 202- 209 ,(2012) , 10.4143/CRT.2012.44.3.202
Xiaoling Du, Jilong Yang, Da Yang, Wei Tian, Ze Zhu, The genetic basis for inactivation of Wnt pathway in human osteosarcoma BMC Cancer. ,vol. 14, pp. 450- 450 ,(2014) , 10.1186/1471-2407-14-450
Oscar Krijgsman, Beatriz Carvalho, Gerrit A. Meijer, Renske D.M. Steenbergen, Bauke Ylstra, Focal chromosomal copy number aberrations in cancer—Needles in a genome haystack Biochimica et Biophysica Acta. ,vol. 1843, pp. 2698- 2704 ,(2014) , 10.1016/J.BBAMCR.2014.08.001